SEC 8-K and 6-K filings classified by Claude with reasoning, plus Form 4 insider transactions. Ingested from EDGAR’s filing stream in near-real time, reconciled overnight.
Showing material events only. Routine administrative filings — bylaw amendments, technical fund updates, procedural FD disclosures — are filtered out so the front page stays signal-dense.
Spyre Therapeutics announced positive Phase 2 SKYLINE trial topline results for SPY002 in ulcerative colitis, meeting the primary endpoint with a statistically significant 10.7-point RHI reduction (p<0.0001) and demonstrating a favorable safety profile. This material clinical milestone represents a significant development in the company's pipeline that would affect investor assessment of regulatory prospects and commercial value.
View raw filing on EDGAR →This is a classic Item 5.07 disclosure reporting the results of Toast's June 12, 2026 annual meeting of stockholders. The filing presents voting outcomes for three proposals: election of three Class II directors (Kent Bennett, Susan Chapman-Hughes, and Mark Hawkins), ratification of Ernst & Young LLP as independent auditor, and advisory approval of named executive officer compensation. All three proposals passed with substantial majorities, making this a routine but material shareholder vote results disclosure.
View raw filing on EDGAR →This Item 5.07 disclosure reports the results of Priority Technology Holdings' 2026 annual meeting of stockholders held on June 11, 2026, including voting outcomes on four proposals: election of six directors, approval of an amendment to the equity incentive plan, advisory vote on executive compensation, and ratification of KPMG LLP as auditor. The filing presents vote tallies (For/Against/Abstain/Broker Non-Votes) for each proposal, which is the core content of a shareholder vote results disclosure.
View raw filing on EDGAR →This 6-K discloses FDA approval of Truqap (capivasertib) in combination with abiraterone and prednisone for PTEN-deficient metastatic prostate cancer, based on positive Phase III CAPItello-281 trial results showing a 19% reduction in risk of disease progression or death. This is a material regulatory milestone and product approval event that expands AstraZeneca's oncology portfolio into a second tumor type, representing a significant operational and commercial development rather than a discrete financial, governance, or legal event.
View raw filing on EDGAR →The 6-K discloses HSBC's declaration and payment of a first interim dividend for 2026 of US$0.10 per ordinary share (US$0.50 per ADS), payable on 26 June 2026. This is a routine but material capital distribution to shareholders that would affect investor assessment of capital allocation and shareholder returns.
View raw filing on EDGAR →The filing discloses a press release announcing quarterly financial results for the period ended April 30, 2026, filed under Item 2.02 (Results of Operations and Financial Condition). This is a standard earnings release disclosure, which is material to investors as it provides periodic financial performance information essential to assessing the registrant's financial condition and operating results.
View raw filing on EDGAR →The filing discloses entry into a Vice Chairman Agreement with Mark Iwanowski, appointing him to serve as Vice Chairman in an advisory capacity effective June 12, 2026. Although the position is non-executive and advisory (not a Board seat or officer role under the Exchange Act), the appointment of a high-profile strategic advisor with substantial technology and M&A experience to a named executive-level position is material to investors assessing the company's leadership and strategic direction. The equity compensation structure ($150,000 annual NSOs plus performance-based grants) reinforces the materiality of this appointment.
View raw filing on EDGAR →SUN entered into a Master Services and Digital Platform Agreement with Phoenix Dance Theatre valued at approximately US$350,000 over 36 months. While Item 1.01 typically covers M&A activity (acquisitions, mergers, dispositions), this disclosure describes a material services contract rather than a change of control or acquisition. The agreement is material to investors as it represents a significant multi-year revenue commitment and strategic validation of the Company's business model, but does not constitute a traditional M&A transaction, making "other_material" the most appropriate classification.
View raw filing on EDGAR →The filing discloses entry into a binding Letter of Intent for a material business combination between Nixxy and Tachyon Corporation, with Tachyon valued at approximately $1 billion. The transaction will result in a change of control, with Tachyon shareholders expected to hold at least 90% of the combined company post-closing. This is a classic M&A activity disclosure under Item 1.01, involving a multi-step business combination creating a publicly traded digital infrastructure platform company.
View raw filing on EDGAR →Forward Industries disclosed non-binding acquisition proposals to two companies (SkyAI and Solana Company) made in June 2026, both of which were rejected or expired without response by June 12, 2026. While these are M&A-related disclosures, they involve rejected non-binding proposals rather than entry into, completion of, or termination of a material acquisition agreement, making them fall outside the core M&A activity definition. The disclosure is material to investors as it signals strategic intent and potential capital deployment, but the lack of binding commitment or definitive agreement makes "other_material" the most appropriate classification.
View raw filing on EDGAR →Virgin Galactic held its Annual Meeting on June 11, 2026, with shareholders voting on five proposals including director elections, auditor ratification, say-on-pay, equity plan approval, and say-on-frequency of say-on-pay votes.
View raw filing on EDGAR →Shareholders approved the Fourth Amended and Restated 2019 Incentive Award Plan, which materially expands the equity compensation framework by increasing available shares by 9.45 million and extending the grant period through 2036.
View raw filing on EDGAR →Repay Holdings Corp entered into a First Amendment to its Credit Agreement that materially modifies the Company's debt facilities, including reducing the term loan maturity from June 1, 2033 to June 1, 2032 and revising springing maturity provisions related to the 2.875% Convertible Senior Notes due 2029. These modifications to the Company's debt structure represent material changes to its financing arrangements.
View raw filing on EDGAR →Splash Beverage Group announced a "strategic investment" in Avicanna Inc. via press release on June 15, 2026. While the disclosure is limited and filed under Item 7.01 (Regulation FD Disclosure) rather than the more formal Item 1.01 (Business Combinations), a strategic investment in another company constitutes a material acquisition or investment activity that would affect a reasonable investor's assessment of the registrant's capital allocation and strategic direction. The modest confidence reflects the sparse detail provided and the Item 7.01 classification, which suggests the company may not view this as a formal business combination requiring full Item 1.01 disclosure.
View raw filing on EDGAR →This Item 8.01 disclosure provides a comprehensive NAV update for Invesco Real Estate Income Trust as of May 31, 2026, including detailed breakdowns of NAV per share by class ($26.09–$28.33), valuation methodology, key assumptions (discount rates 7.2%–9.6%, exit cap rates 5.5%–7.3%), and portfolio composition (70 properties, 94% occupancy, 30% leverage). While NAV disclosures are routine for non-traded REITs, this filing is material to investors as it directly affects share pricing, repurchase valuations, and investment decisions. The disclosure does not fit more specific event categories (no earnings release, impairment, going concern, or litigation), making "other_material" the appropriate classification.
View raw filing on EDGAR →The disclosure centers on the appointment of Andrew Taylor as Vice President and Chief Accounting Officer effective August 28, 2026, a material executive position. While S. Denise Sumner's retirement is also disclosed, the filing's substantive focus is on Taylor's appointment with detailed background information (prior PWC experience, credentials, and confirmations of no conflicts). The Chief Accounting Officer role is material to investors' assessment of financial reporting oversight and internal controls.
View raw filing on EDGAR →This Item 5.07 disclosure presents the results of XPEL's 2026 annual meeting of stockholders held on June 10, 2026, including voting outcomes on three matters: election of six directors, ratification of Deloitte & Touche as independent auditor, and advisory approval of named executive officer compensation. The filing directly matches the shareholder_vote_results event type and is material to investors as it documents the formal governance decisions and shareholder approval outcomes at the annual meeting.
View raw filing on EDGAR →This is a classic Item 5.07 disclosure reporting the results of Hims & Hers' Annual Meeting of Stockholders held on June 11, 2026. The filing tabulates voting outcomes for three proposals: election of nine directors, ratification of KPMG LLP as independent auditor, and advisory approval of executive compensation. All three proposals passed with substantial majorities, making this a routine but material shareholder vote results disclosure.
View raw filing on EDGAR →This is a classic Item 5.07 disclosure reporting the results of Porch Group's annual meeting of stockholders held on June 10, 2026. The filing presents voting tallies for four proposals: election of eight directors (96.8%–98.9% approval), ratification of Grant Thornton LLP as auditor (99.9% approval), advisory approval of named executive officer compensation (93% approval), and adoption of the Employee Stock Purchase Plan (99.8% approval). These results are material to investors as they confirm the composition of the board and key governance decisions.
View raw filing on EDGAR →The Board appointed Andrew Gengos as Chief Financial Officer and Treasurer, effective on or before July 16, 2026, succeeding Mallory Morales in the principal financial officer role. While the disclosure also includes compensatory arrangements (base salary of $530,000, 40% target bonus, and 650,000 option grant), the principal disclosed action is the appointment of a named executive officer to a key financial leadership position. This is material to investors as CFO changes affect financial oversight and strategy.
View raw filing on EDGAR →ESS Tech received a written notice from NYSE on June 9, 2026, indicating failure to satisfy the continued listing standard under Section 802.01C due to average closing price below $1.00 per share. The company has a six-month cure period and may pursue remedies including a reverse stock split to regain compliance.
View raw filing on EDGAR →The filing discloses the appointment of Laura Boettcher as Chief Operating Officer of Hippo Holdings Inc., effective June 10, 2026. While the disclosure also includes compensatory details (base salary of $450,000, bonus eligibility, and equity grants), the principal action is her appointment to a C-suite officer role. The appointment of a COO is material to investors as it reflects organizational leadership changes and operational oversight structure.
View raw filing on EDGAR →Vivakor converted $103,100.78 in convertible promissory notes into 355,979 shares of common stock in an unregistered private placement under Section 4(a)(2). The underlying Lender Notes total $5.1 million in principal, representing a material dilutive issuance to existing shareholders.
View raw filing on EDGAR →Vivakor issued a press release on June 9, 2026 disclosing the Company's first quarter 2026 financial results. The earnings announcement was furnished along with operational updates and shareholder meeting notices issued on June 10 and 11, 2026.
View raw filing on EDGAR →This press release announces FDA approval of Obagi® saypha® ChIQ™, a new injectable hyaluronic acid gel product for the Obagi Medical brand (owned by Waldencast). The approval expands Obagi's injectable portfolio and strengthens its position in the dermal filler market. This is a material operational/product milestone—a regulatory approval that materially expands the company's addressable market in the fast-growing U.S. dermal filler category and advances its strategy to establish Obagi as a comprehensive leader in medical aesthetics. While not a discrete M&A, litigation, or financial event, the approval of a new product with significant market potential is material to investors assessing the company's growth trajectory and competitive positioning.
View raw filing on EDGAR →This is a clear disclosure of shareholder vote results from Nextdoor's June 9, 2026 Annual Meeting of Stockholders. The filing reports voting outcomes on three proposals: election of a Class II director (David Sze), ratification of Ernst & Young LLP as independent auditor, and advisory approval of named executive officer compensation. The detailed vote tallies and passage of all three proposals are the core content of Item 5.07, which is the standard Item for reporting shareholder meeting results.
View raw filing on EDGAR →This is a clear disclosure of shareholder voting results from Victoria's Secret & Co.'s June 11, 2026 annual meeting, covering three proposals: election of nine directors, advisory approval of named executive officer compensation, and ratification of Ernst & Young LLP as independent auditor. The detailed voting tallies (For, Against, Abstain, Broker Non-Votes) for each proposal are the hallmark of Item 5.07 shareholder vote results disclosures, which are material to investors assessing corporate governance and board composition.
View raw filing on EDGAR →Castellum announced that its joint venture won a position on a $250 million U.S. Navy logistics IT multiple award contract. While this represents a significant business development and potential revenue opportunity, it does not fit neatly into the more specific event categories (it is not an M&A transaction, earnings release, executive change, or other defined material event type). The contract award is material to investors as a substantial government contract win, but the disclosure is best classified as other_material given the absence of a more precise taxonomy match.
View raw filing on EDGAR →This disclosure reports the Net Asset Value (NAV) per share as of May 31, 2026, for a diversified real estate income trust across multiple share classes. NAV reporting is a standard and material disclosure for REITs and closed-end funds, as it directly informs investors of the per-share value of their holdings and is used to assess performance and pricing. While this is routine periodic reporting rather than an unexpected event, it is material to investors' assessment of the registrant's financial position and does not fit neatly into the more specific event categories (e.g., it is not an earnings release with comprehensive financial results, nor a restatement, impairment, or other discrete event).
View raw filing on EDGAR →The 6-K discloses termination of an at-the-market (ATM) sales agreement with AC Sunshine Securities LLC under which the Company sold 39,248,940 Class A Ordinary Shares for gross proceeds of $30.97 million. While the primary disclosure is the termination, the material event is the dilutive equity issuance itself—a substantial unregistered offering that raised significant capital and diluted existing shareholders. The magnitude (39+ million shares, ~$31 million proceeds) and the ATM structure (characteristic of dilutive capital raises at smaller issuers) make this material to investors.
View raw filing on EDGAR →The CEO and principal shareholder voluntarily surrendered 3,000,000 shares (approximately 49% of outstanding shares) for zero consideration, reducing total outstanding shares from 6,134,780 to 3,134,780. While this is a capital structure change rather than a traditional M&A, restatement, or executive departure, it materially affects share count, ownership concentration, and EPS calculations—information a reasonable investor would consider significant. The voluntary nature and zero-consideration treatment as a capital contribution distinguish this from standard buybacks or dilutive issuances.
View raw filing on EDGAR →This Item 8.01 disclosure provides a comprehensive NAV update as of May 31, 2026, including detailed valuation methodologies, portfolio composition, and recent loan originations totaling approximately $479 million. While the filing acknowledges that "transactions or events have occurred since May 31, 2026 that could have a material impact on our NAV per share," the disclosure itself is primarily informational regarding NAV calculation and portfolio status rather than announcing a specific material event (such as impairment, covenant breach, or going concern). The NAV update and portfolio activity are material to investors in this closed-end fund, but do not fit neatly into more specific event categories.
View raw filing on EDGAR →Elliott Rodgers, a Board member, tendered his resignation effective June 15, 2026, in connection with his appointment as an executive officer at Kohl's Corporation. The principal disclosed action is a director's departure from the Board. While the filing notes the Board intends to decrease size to 11 directors, the core event is Rodgers' resignation, making this an exec_departure rather than a routine administrative matter.
View raw filing on EDGAR →This is a clear disclosure of shareholder voting results from the June 10, 2026 Annual Meeting of Stockholders, including election of directors (Evelyn Dilsaver and Mark Hancock), ratification of Ernst & Young LLP as independent auditor, and advisory approval of named executive officer compensation. The filing explicitly states all three proposals were approved, which is the core content of Item 5.07.
View raw filing on EDGAR →The FDA accepted Inhibrx's Biologics License Application (BLA) for ozekibart (INBRX-109) with a PDUFA goal date of April 14, 2027, representing a material regulatory milestone in the company's clinical development program.
View raw filing on EDGAR →Ares Core Infrastructure Fund's wholly-owned subsidiaries entered into a $910 million senior secured term loan credit facility on June 9, 2026, representing a material refinancing and capital structure transaction affecting the Fund's leverage position and financial obligations.
View raw filing on EDGAR →The Fund terminated its Initial Rover Credit Agreement (approximately $1.09 billion outstanding) and repaid all loans, replacing it with a new Rover Credit Agreement—a material refinancing transaction affecting the registrant's capital structure and debt obligations.
View raw filing on EDGAR →The Rover Borrower (a portfolio company of the Fund) entered into an interest rate swap with Morgan Stanley Bank on June 9, 2026, covering 50% of outstanding borrowings under the Rover Term Loan at a fixed rate of 4.085% through June 2033, materially affecting the Fund's interest rate exposure and debt service obligations.
View raw filing on EDGAR →The filing discloses a distribution payment of $0.19 per share (gross) across five classes of common stock on June 12, 2026, with net distributions ranging from $0.1770 to $0.1900 after servicing fees. While distribution announcements are routine for REITs and closed-end funds, this disclosure does not fit cleanly into the standard taxonomy categories (it is not an earnings release, which would typically include full financial results). The materiality to shareholders is evident—distributions directly affect investor returns—but the event itself is a routine capital allocation action rather than a material corporate event that signals financial stress, opportunity, or governance change.
View raw filing on EDGAR →Franklin BSP Real Estate Debt, Inc. entered into Amendment No. 2 to an Uncommitted Master Repurchase Agreement with JPMorgan Chase Bank and executed an Amended and Restated Guarantee Agreement whereby the Company assumes guarantor obligations for its subsidiary's repurchase facility. The amendment modifies the agreement's Change of Control provisions and replaces the guarantor, creating material modifications to the Company's direct financial obligations.
View raw filing on EDGAR →This is a classic Item 5.07 disclosure of shareholder vote results from the Company's 2026 annual meeting held on June 15, 2026. The filing reports final voting tallies for two proposals: election of six directors (all elected with substantial majorities) and ratification of Deloitte & Touche LLP as independent auditor (ratified with overwhelming support). Director elections and auditor ratification are material governance matters affecting investor confidence in board composition and financial oversight.
View raw filing on EDGAR →Target held its 2026 Annual Meeting of Shareholders on June 10, 2026, with voting results on seven proposals including director elections, auditor ratification, executive compensation approval, and long-term incentive plan amendments. The filing discloses detailed voting tallies for each proposal.
View raw filing on EDGAR →The filing discloses a material acquisition in progress: IBCP's proposed acquisition of HCB Financial Corp., with a definitive merger agreement signed March 18, 2026. The June 12, 2026 disclosure announces regulatory approvals from the Federal Reserve Bank of Chicago and Michigan Department of Insurance and Financial Services, representing a significant milestone toward completion. This is a classic M&A activity disclosure under Item 8.01, material to investors assessing the registrant's strategic direction and future financial profile.
View raw filing on EDGAR →The disclosure centers on compensatory arrangements for Swen Neufeldt, a Group Vice President, including modifications to his base salary structure (addition of $56,103 cost-of-living adjustment), relocation payments ($20,000), housing allowance ($90,566 annually), and various other benefits totaling substantial additional compensation tied to his international assignment. While the assignment itself is administrative, the material substance of the 8-K Item 5.02 filing is the new compensatory package and benefits arrangement.
View raw filing on EDGAR →This disclosure reports a jury verdict in a wrongful termination and whistleblower protection lawsuit against Ameris Bank, with a total judgment of approximately $79.4 million ($16.525 million in economic/non-economic damages plus $62.9 million in punitive damages). The Company explicitly states the verdict "could have a material adverse effect on the Company's results of operations, financial condition and liquidity," and is evaluating whether an accrual is required for financial reporting purposes, indicating materiality to investors.
View raw filing on EDGAR →The disclosure centers on Kristen Johnson's separation from H2O America, effective July 3, 2026, following a mutual agreement on June 10, 2026. The Company classified the separation as "without cause" and committed to severance payments under her employment agreement. This is a clear executive departure event, material to investors as it affects the composition of management and involves severance obligations.
View raw filing on EDGAR →Santander Holdings USA disclosed its Q2 2026 financial results on June 12, 2026, including results of operations and financial condition for the period.
View raw filing on EDGAR →The filing discloses the election of Vishal Talwar as a director of Fastenal Company effective June 12, 2026, increasing the Board from eleven to twelve members. Mr. Talwar, currently Executive Vice President and Chief Digital and Information Officer at FedEx Corporation, was also appointed to the Nominating and Corporate Governance Committee. This is a clear director appointment that would be material to investors assessing Board composition and governance.
View raw filing on EDGAR →Val Bauduin was designated as Starbucks' principal accounting officer on June 11, 2026, with principal accounting officer responsibility transferring from CFO Cathy Smith to Bauduin. While Bauduin retains his existing SVP title and compensation, the designation of a principal accounting officer is a material executive appointment affecting the company's financial reporting structure and governance. The disclosure emphasizes his background as controller and chief accounting officer at Marriott, underscoring the significance of this accounting leadership role.
View raw filing on EDGAR →Isabella Bank Corporation entered into an Agreement and Plan of Merger with Grand River Commerce, Inc. on June 11, 2026, with a joint press release issued on June 12, 2026. This constitutes entry into a material acquisition/merger transaction, which is a core M&A activity event requiring disclosure under Item 1.01 or related provisions. The disclosure of the executed Merger Agreement and supplemental investor presentation clearly signals a material change of control or acquisition event.
View raw filing on EDGAR →